CLINICAL TRIAL: CLINICAL TRIAL OF CEFTRIAXONE IN SUBJECTS WITH ALS

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objectives of this study are to determine the pharmacokinetics and tolerability of long term ceftriaxone treatment and to subsequently determine the efficacy of this treatment in ALS patients. We will measure multiple aspects of decline in ALS patients and correlate these outcome measures with the change in survival due to treatment effect.